Nexien Biopharma Inc (NXEN)

$0.00 0.00 (-75.44%)
Market Cap 99,000.00
Revenue (ttm) 0.00
Net Income (ttm) -240,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 200
Avg Vol 18,982
Day's Range N/A - N/A
Shares Out 70.77M
Stochastic %K 0%
Beta -1.08
Analysts Strong Buy
Price Target N/A

Company Profile

Nexien BioPharma, Inc. focuses on the formulation, development, and commercialization of cannabinoid-based pharmaceuticals, drug delivery systems, and related technologies for diseases, disorders, and medical conditions in the United States. The company was formerly known as Intiva BioPharma Inc. and changed its name to Nexien BioPharma, Inc. in September 2018. Nexien BioPharma, Inc. is based in Glendale, Colorado.

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 303 495 7583
Address:
4340 East Kentucky Avenue, Suite 206, Glendale, United States
PennyStacksTo1Mill
PennyStacksTo1Mill Aug. 3 at 10:37 PM
$NXEN Quiet here haha 📈📈
0 · Reply
EarningsInsider
EarningsInsider May. 17 at 6:49 PM
Nexien BioPharma, Inc. Files SEC Form 10-Q $NXEN https://www.marketbeat.com/stocks/OTCMKTS/NXEN/sec-filings/
0 · Reply
fla
fla May. 17 at 6:25 PM
$NXEN [15s. delayed] filed form 10-Q on May 17, 14:24:27 https://s.flashalert.me/uVZeh
0 · Reply
Latest News on NXEN
No data available.
PennyStacksTo1Mill
PennyStacksTo1Mill Aug. 3 at 10:37 PM
$NXEN Quiet here haha 📈📈
0 · Reply
EarningsInsider
EarningsInsider May. 17 at 6:49 PM
Nexien BioPharma, Inc. Files SEC Form 10-Q $NXEN https://www.marketbeat.com/stocks/OTCMKTS/NXEN/sec-filings/
0 · Reply
fla
fla May. 17 at 6:25 PM
$NXEN [15s. delayed] filed form 10-Q on May 17, 14:24:27 https://s.flashalert.me/uVZeh
0 · Reply